Atara Biotherapeutics
ATRA
ATRA
118 hedge funds and large institutions have $146M invested in Atara Biotherapeutics in 2023 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 36 increasing their positions, 42 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
118
Holders Change
-7
Holders Change %
-5.6%
% of All Funds
1.86%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
22
Increased
36
Reduced
42
Closed
29
Calls
$2.23M
Puts
$37K
Net Calls
+$2.19M
Net Calls Change
-$2.59M
Top Buyers
| 1 |
1
Millennium Management
New York
|
$2.52M |
| 2 |
6CM
2
683 Capital Management
New York
|
$1.61M |
| 3 |
3
Acadian Asset Management
Boston,
Massachusetts
|
$1.13M |
| 4 |
4
Renaissance Technologies
New York
|
$3.41M |
| 5 |
BG
5
Baupost Group
Boston,
Massachusetts
|
$15.7M |
